rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
14 Pt 1
|
pubmed:dateCreated |
2006-7-21
|
pubmed:abstractText |
Specific activating mutations within the epidermal growth factor receptor (EGFR) identify a subset of non-small cell lung cancers with dramatic sensitivity to the specific tyrosine kinase inhibitors (TKI), gefitinib and erlotinib. Despite the abundant expression of EGFR protein in a broad range of epithelial cancers, EGFR mutations have not been reported in a substantial fraction of other cancers. Given recent reports of TKI-responsive cases of esophageal and pancreatic cancer, this study was designed to determine the prevalence of EGFR mutations in these gastrointestinal cancers.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1078-0432
|
pubmed:author |
pubmed-author:BellDaphne WDW,
pubmed-author:BranniganBrian WBW,
pubmed-author:ClarkJeff WJW,
pubmed-author:DriscollDavid RDR,
pubmed-author:FerryDavidD,
pubmed-author:FuchsCharles SCS,
pubmed-author:HaberDaniel ADA,
pubmed-author:HarrisPatricia LPL,
pubmed-author:HaserlatSara MSM,
pubmed-author:JankowskiJanuszJ,
pubmed-author:KulkeMatthew HMH,
pubmed-author:KwakEunice LEL,
pubmed-author:LauwersGregory YGY,
pubmed-author:MuirBethB,
pubmed-author:OkimotoRoss ARA,
pubmed-author:RyanDavid PDP,
pubmed-author:SettlemanJeffJ,
pubmed-author:SgroiDennis CDC,
pubmed-author:ThayerSarah PSP
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4283-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16857803-Adenocarcinoma,
pubmed-meshheading:16857803-Antineoplastic Agents,
pubmed-meshheading:16857803-Cell Transformation, Neoplastic,
pubmed-meshheading:16857803-DNA Mutational Analysis,
pubmed-meshheading:16857803-Esophageal Neoplasms,
pubmed-meshheading:16857803-Exons,
pubmed-meshheading:16857803-Genotype,
pubmed-meshheading:16857803-Humans,
pubmed-meshheading:16857803-Mutation,
pubmed-meshheading:16857803-Pancreatic Neoplasms,
pubmed-meshheading:16857803-Protein Structure, Tertiary,
pubmed-meshheading:16857803-Receptor, Epidermal Growth Factor
|
pubmed:year |
2006
|
pubmed:articleTitle |
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.
|
pubmed:affiliation |
Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|